NEOGEN CORP·4

Oct 31, 12:11 PM ET

Lilly Jason Warren 4

4 · NEOGEN CORP · Filed Oct 31, 2023

Insider Transaction Report

Form 4
Period: 2023-10-26
Lilly Jason Warren
Vice President
Transactions
  • Exercise/Conversion

    Common Stock (Right to Buy)

    2023-10-26+25,004225,196 total
    Exercise: $15.48Exp: 2030-10-26Common Stock (25,004 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-10-26+14,57434,038 total
    Exercise: $15.48Exp: 2026-10-26Common Stock (14,574 underlying)
Footnotes (1)
  • [F1]Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT